Skip to main content

Menu

Select a tool from the sidebar

Create your free account now!

Sign in to customize and use tools on the sidebar.

Sign InCreate free account
Sanofi logo
SAN.PA
Sanofi
13:12:22
74.82 €
0.0000 (%0.00)
Previous Close: 73.34
Day Low₺73.95
Day High₺75.4
Bid
Ask
Overview
Technicals
Financial Statements
Comments
Archive

SAN.PA: Sanofi Financials

Sanofi Income Statement

Total revenue
Net income
Gross margin TTM
70.09%
Operating margin TTM
32.67%
Net profit margin TTM
17.91%
Return on investment TTM
10.95%
Period end31/12/202531/12/202431/12/202331/12/2022
Total revenue43,626,000,00044,286,000,00041,109,000,00040,304,000,000
Operating income14,251,000,00014,450,000,00012,980,000,00013,149,000,000
Net income7,813,000,0005,560,000,0005,400,000,0008,371,000,000

All line items

Line item31/12/202531/12/202431/12/202331/12/2022
Total revenue43,626,000,00044,286,000,00041,109,000,00040,304,000,000
Cost of revenue13,049,000,00013,195,000,00012,619,000,00011,869,000,000
Gross profit30,577,000,00031,091,000,00028,490,000,00028,435,000,000
Research and development expenses7,842,000,0007,394,000,0006,507,000,0006,501,000,000
General and administrative expenses0000
Selling and marketing expenses0000
Selling, general and administrative expenses9,543,000,0009,247,000,0009,003,000,0008,785,000,000
Other expenses-1,059,000,000000
Operating expenses16,326,000,00016,641,000,00015,510,000,00015,286,000,000
Cost and expenses29,375,000,00029,836,000,00028,129,000,00027,155,000,000
Net interest income-169,000,000-158,000,00018,000,000-221,000,000
Interest income394,000,000438,000,000540,000,000173,000,000
Interest expense563,000,000596,000,000522,000,000394,000,000
Depreciation and amortization5,722,000,0002,795,000,0002,955,000,0002,712,000,000
EBITDA12,460,000,00011,664,000,00011,076,000,00013,093,000,000
EBIT6,738,000,0008,869,000,0008,121,000,00010,381,000,000
Non-operating income (excl. interest)7,513,000,0005,581,000,0004,859,000,0002,768,000,000
Operating income14,251,000,00014,450,000,00012,980,000,00013,149,000,000
Total other income/expenses (net)-8,231,000,000-7,692,000,000-6,865,000,000-3,157,000,000
Income before tax6,020,000,0006,758,000,0006,115,000,0009,992,000,000
Income tax expense1,043,000,0001,204,000,0001,017,000,0001,909,000,000
Net income from continuing operations4,977,000,0005,554,000,0005,098,000,0008,083,000,000
Net income from discontinued operations2,874,000,00064,000,000338,000,000401,000,000
Other adjustments to net income0000
Net income7,813,000,0005,560,000,0005,400,000,0008,371,000,000
Net income deductions0000
Bottom line net income7,813,000,0005,496,000,0005,400,000,0008,371,000,000
EPS6447
Diluted EPS6447
Weighted average shares outstanding1,220,400,0001,251,400,0001,251,700,0001,251,900,000
Weighted average diluted shares outstanding1,220,400,0001,251,400,0001,256,400,0001,251,900,000

Sanofi Balance Sheet

Total assets
Total liabilities & equity
Liquidity ratio MRQ
—
Current ratio MRQ
—
Long-term debt / assets MRQ
15,715,000,000%
Total debt / assets MRQ
—
Period end31/12/202531/12/202431/12/202331/12/2022
Total assets126,806,000,000132,798,000,000126,464,000,000126,722,000,000
Total liabilities55,096,000,00054,941,000,00052,111,000,00051,570,000,000
Total equity71,376,000,00077,507,000,00074,040,000,00074,784,000,000

All line items

Line item31/12/202531/12/202431/12/202331/12/2022
Cash and cash equivalents7,657,000,0007,441,000,0008,710,000,00012,736,000,000
Short-term investments0486,000,000270,000,000663,000,000
Cash and short-term investments7,657,000,0007,927,000,0008,980,000,00013,399,000,000
Net receivables397,000,00010,629,000,00011,040,000,00010,746,000,000
Accounts receivable07,677,000,0008,433,000,0008,424,000,000
Other receivables397,000,0002,952,000,0002,607,000,0002,322,000,000
Inventory09,431,000,0009,666,000,0008,960,000,000
Prepaid expenses0895,000,000768,000,000714,000,000
Other current assets22,899,000,00013,706,000,000216,000,000291,000,000
Total current assets30,953,000,00042,588,000,00030,670,000,00034,110,000,000
Property, plant and equipment (net)11,511,000,00011,601,000,00011,814,000,00011,684,000,000
Goodwill67,561,000,00043,384,000,00049,404,000,00049,892,000,000
Intangible assets022,629,000,00024,319,000,00021,640,000,000
Goodwill and intangible assets67,561,000,00066,013,000,00073,723,000,00071,532,000,000
Long-term investments03,259,000,0002,666,000,0002,765,000,000
Tax assets07,967,000,0006,427,000,0005,381,000,000
Other non-current assets16,781,000,0001,370,000,0001,164,000,0001,249,000,000
Total non-current assets95,853,000,00090,210,000,00095,794,000,00092,611,000,000
Other assets0001,000,000
Total assets126,806,000,000132,798,000,000126,464,000,000126,722,000,000
Total payables23,678,000,0009,563,000,0009,265,000,0008,521,000,000
Accounts payable22,927,000,0007,551,000,0007,328,000,0006,813,000,000
Other payables751,000,0002,012,000,0001,937,000,0001,708,000,000
Accrued expenses0000
Short-term debt4,614,000,0004,209,000,0002,045,000,0004,174,000,000
Capital lease obligations (current)0261,000,000275,000,000277,000,000
Tax payables01,134,000,000597,000,000574,000,000
Deferred revenue000269,000,000
Other current liabilities54,000,00015,129,000,00012,622,000,00010,733,000,000
Total current liabilities28,346,000,00029,162,000,00024,207,000,00023,974,000,000
Long-term debt15,715,000,00011,791,000,00014,347,000,00014,857,000,000
Capital lease obligations (non-current)1,467,000,0001,645,000,0001,755,000,0001,904,000,000
Deferred revenue (non-current)0000
Deferred tax liabilities (non-current)1,666,000,0002,166,000,0001,857,000,0001,841,000,000
Other non-current liabilities7,902,000,00010,177,000,0009,945,000,0008,994,000,000
Total non-current liabilities26,750,000,00025,779,000,00027,904,000,00027,596,000,000
Other liabilities0000
Capital lease obligations1,467,000,0001,906,000,0002,030,000,0002,181,000,000
Total liabilities55,096,000,00054,941,000,00052,111,000,00051,570,000,000
Treasury stock0-840,000,000-1,184,000,000-706,000,000
Preferred stock0000
Common stock02,526,000,0002,530,000,0002,522,000,000
Retained earnings0000
Additional paid-in capital00313,000,000125,000,000
Accumulated other comprehensive income/loss64,436,000,00070,561,000,00067,437,000,00068,185,000,000
Other stockholders' equity71,376,000,0005,260,000,0004,944,000,0004,658,000,000
Total stockholders' equity71,376,000,00077,507,000,00074,040,000,00074,784,000,000
Total equity71,710,000,00077,857,000,00074,353,000,00075,152,000,000
Minority interest334,000,000350,000,000313,000,000368,000,000
Total liabilities and total equity126,806,000,000132,798,000,000126,464,000,000126,722,000,000
Total investments7,421,000,0003,745,000,0002,936,000,0003,428,000,000
Total debt21,796,000,00017,906,000,00018,422,000,00021,212,000,000
Net debt14,139,000,00010,465,000,0009,712,000,0008,476,000,000

Sanofi Cash Flow Statement

Cash from operations
Cash from investing
Cash flow / share TTM
—
Revenue / share TTM
—
Operating cash flow TTM
—
Period end31/12/202531/12/202431/12/202331/12/2022
Cash from operations10,750,000,0009,081,000,00010,258,000,00010,526,000,000
Cash from investing-2,447,000,000-4,407,000,000-6,200,000,000-2,075,000,000
Cash from financing-8,207,000,000-5,763,000,000-8,052,000,000-5,821,000,000
Net change in cash-54,000,000-1,269,000,000-4,026,000,0002,638,000,000

All line items

Line item31/12/202531/12/202431/12/202331/12/2022
Net income4,939,000,0005,496,000,0005,062,000,0008,371,000,000
Depreciation and amortization5,722,000,0003,586,000,0004,429,000,0003,420,000,000
Deferred income tax-2,439,000,000-802,000,000-1,233,000,000-578,000,000
Stock-based compensation000245,000,000
Change in working capital1,795,000,000-615,000,000413,000,000-794,000,000
Accounts receivable-1,202,000,000-28,000,000-472,000,000-500,000,000
Inventory-39,000,000-477,000,000-866,000,000-918,000,000
Accounts payable398,000,000789,000,000258,000,000340,000,000
Other working capital2,638,000,000-899,000,0001,493,000,000284,000,000
Other non-cash items733,000,0001,416,000,0001,587,000,000-138,000,000
Net cash from operating activities10,750,000,0009,081,000,00010,258,000,00010,526,000,000
Investments in property, plant and equipment-3,618,000,000-3,235,000,000-3,253,000,000-2,201,000,000
Acquisitions (net)847,000,000-2,524,000,0001,012,000,000-858,000,000
Purchases of investments-10,078,000,0000-134,000,000-488,000,000
Sales/maturities of investments0042,000,0000
Other investing activities10,402,000,0001,352,000,000-3,867,000,0001,472,000,000
Net cash from investing activities-2,447,000,000-4,407,000,000-6,200,000,000-2,075,000,000
Net debt issuance1,837,000,000-894,000,000-3,137,000,000-954,000,000
Long-term net debt issuance2,937,000,000-953,000,000-3,901,000,000-1,169,000,000
Short-term net debt issuance-1,100,000,00059,000,000765,000,000215,000,000
Net stock issuance-4,853,000,000-115,000,000-398,000,000-497,000,000
Net common stock issuance-4,853,000,000-115,000,000-398,000,000-309,000,000
Common stock issuance177,000,000187,000,000195,000,000188,000,000
Common stock repurchased-5,030,000,000-302,000,000-593,000,000-497,000,000
Net preferred stock issuance000-188,000,000
Net dividends paid-4,772,000,000-4,704,000,000-4,454,000,000-4,168,000,000
Common dividends paid-4,772,000,000-4,704,000,000-4,454,000,000-4,168,000,000
Preferred dividends paid0000
Other financing activities-419,000,000-50,000,000-63,000,000-202,000,000
Net cash from financing activities-8,207,000,000-5,763,000,000-8,052,000,000-5,821,000,000
Effect of FX changes on cash-150,000,000-180,000,000-32,000,0008,000,000
Net change in cash-54,000,000-1,269,000,000-4,026,000,0002,638,000,000
Cash at end of period7,387,000,0007,441,000,0008,710,000,00012,736,000,000
Cash at beginning of period7,441,000,0008,710,000,00012,736,000,00010,098,000,000
Operating cash flow10,750,000,0009,081,000,00010,258,000,00010,526,000,000
Capital expenditure-1,762,000,000-3,195,000,000-1,619,000,000-2,201,000,000
Free cash flow8,988,000,0005,886,000,0008,639,000,0008,325,000,000
Income taxes paid03,291,000,0002,623,000,0002,452,000,000
Interest paid0587,000,000559,000,000380,000,000